Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2010
12/01/2010CN101903402A Humanized antibodies against TL1A
12/01/2010CN101903389A Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy
12/01/2010CN101903338A Phenyl acetic acid derivatives as inflammation modulators
12/01/2010CN101899416A Recombinant rat myeloma cell NS0-F10 and application thereof
12/01/2010CN101899114A Antibodies against PD-1 and uses therefor
12/01/2010CN101899099A X4 peptide synthetic product and application thereof
12/01/2010CN101899093A X2 polypeptide synthesis product and application thereof.
12/01/2010CN101899090A Saturated fatty chain alcohol His-Gly-AA tripeptide ester, synthetic method and application thereof
12/01/2010CN101899089A Saturated fatty chain amine His-Gly-AA tripeptide amide, synthetic method and application thereof
12/01/2010CN101899088A Saturated fat chain acid His-Gly-AA tripeptide amide, and synthesis method and use thereof
12/01/2010CN101899087A Saturated fatty chain amine Glu-Asp-Gly tripeptide amides as well as synthesis method and application thereof
12/01/2010CN101899086A Saturated fatty chain acid Glu-Asp-Gly tripeptide amide, synthetic method and application thereof
12/01/2010CN101899085A Saturated fatty chain alcohol Glu-Asp-Gly tripeptide ester, synthetic method and application thereof
12/01/2010CN101899047A Beta-amino tetrahydropyrazine, tetrahydropyrimidine and tetrahydropyridine used as dipeptidy peptidase inhibitors for curing or preventing diabetes
12/01/2010CN101899004A Sinomenine derivatives and preparation method and medical application thereof
12/01/2010CN101897983A Monocyte-specific particulate delivery vehicle
12/01/2010CN101897970A Compositions and methods for treating diabetes
12/01/2010CN101897966A Cynomorium songaricum immunological adjuvant and influenza vaccine comprising same
12/01/2010CN101897964A Medicament for preventing autoimmune disease
12/01/2010CN101897961A Preparation method for B cell CD 22 extracellular inhibitive peptide fragment B2285 vaccines
12/01/2010CN101897955A Cell factor composition for immune regulation
12/01/2010CN101897954A Composition, preparation method thereof and use thereof
12/01/2010CN101897916A Quality control method of skin-care gel
12/01/2010CN101897831A Method for extracting and separating medlar total alkaloids from medlar
12/01/2010CN101897768A Drug composition for resisting inflammation and easing pain and preparation method and application thereof
12/01/2010CN101897766A Anti-inflammatory and analgesic medicine composition as well as preparation method and application thereof
12/01/2010CN101897752A Chinese medicinal composition and preparation method thereof
12/01/2010CN101897724A Method for producing a soft tissue filler and method for producing an adipose tissue transplant
12/01/2010CN101897684A Coenzyme Q10 injection medicinal composition packaged with plastic container
12/01/2010CN101897680A Liquid capsule preparation, preparation method and application thereof
12/01/2010CN101897662A Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
12/01/2010CN101554203B Biological feed
12/01/2010CN101396368B Use of iso-glycyrrhizic acid and salt thereof in treating allergic rhinitis
12/01/2010CN101342313B Health care granular formulation, preparation and application thereof
12/01/2010CN101323643B Optimized TACI-Fc fuse protein
12/01/2010CN101301427B Medicament composition and preparation and application thereof
12/01/2010CN101293073B Chinese medicinal composition for treating systematic lupus erythematosus
12/01/2010CN101156928B A Subhealth treating Chinese medicine composition and method of making the same
12/01/2010CN101129373B Method for preparing Imiquimod chitosannano granule
11/2010
11/30/2010US7842787 Kinase insert domain-containing receptor (KDR) specific immunoglobulin for monitoring tumor angiogenesis
11/30/2010US7842699 administering 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or salts, for the treatment of dermatitis, Crohn's disease, inflammatory bowel disease, transplant rejection, lupus, multiple sclerosis, arthritis, psoriasis, diabetes and autoimmune diseases
11/30/2010US7842698 Autoimmune diseases; antiinflamamtory agents, cardiovascular disorders; neurodegenerative diseases, kidney diseases, anticancer agents; platelet aggregation
11/30/2010US7842501 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/30/2010CA2513440C Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
11/30/2010CA2477208C Substituted phenylalkanoic acid derivatives and use thereof
11/30/2010CA2456817C Alkyne-aryl-naphthyridin-4 (1h)-one derivatives as type iv phosphodiesterase inhibitor
11/30/2010CA2295876C Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/25/2010WO2010135704A2 Secretion-related bacterial proteins for nlrc4 stimulation
11/25/2010WO2010135563A1 Recombinant bacterium and methods of antigen and nucleic acid delivery
11/25/2010WO2010135452A2 Pyrazinamide for the treatment of leishmaniases
11/25/2010WO2010135014A1 Tri-cyclic pyrazolopyridine kinase inhibitors
11/25/2010WO2010134533A1 2,4-diaminopyrimidine compound having aminocyclohexylalkyl group
11/25/2010WO2010133836A1 Fused bicyclic pyrazole derivatives as kinase inhibitors
11/25/2010WO2010133574A1 Opioid receptors stimulating compounds (thymoquinone, nigella sativa) and food allergy
11/25/2010WO2010133475A2 Infant feeding formulas comprising probiotic micro-organisms
11/25/2010WO2010133472A2 Growing up milks containing probiotic micro-organisms
11/25/2010WO2010100515A3 Fractions of wheat germ ferment
11/25/2010WO2010090407A3 A composition comprising an extract of puerariae radix showing immune enhancing activity and the use thereby
11/25/2010WO2010083203A3 Non-embryonic stem cells and uses thereof
11/25/2010WO2010082798A3 Composition containing extracts of fuscoporia obliqua, ganoderma lucidum and phellinus linteus for promoting the proliferation of hematopoietic stem cells
11/25/2010WO2010080007A3 Lipoproteins derived from gram-positive bacteria functioning as toll-like receptor 2 ligand
11/25/2010WO2009137871A8 Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells
11/25/2010US20100299766 Mouse models carrying a knock-out mutation of the qpctl-gene
11/25/2010US20100298414 Development of a preventive vaccine for filovirus infection in primates
11/25/2010US20100298408 Oligonucleotide Compositions with Enhanced Efficiency
11/25/2010US20100298395 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
11/25/2010US20100298373 Oxadiazole derivatives active on sphingosine-1-phosphate (sip)
11/25/2010US20100298370 Benzothiazolyl thienopyridine derivatives and uses thereof
11/25/2010US20100298368 Antagonists of pgd2 receptors
11/25/2010US20100298358 Naphthamide Derivatives As Multi-Target Protein Kinase Inhibitors and Histone Deacetylase Inhibitors
11/25/2010US20100298355 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
11/25/2010US20100298334 N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
11/25/2010US20100298330 Haloallylamine inhibitors of ssao/vap-1 and uses therefor
11/25/2010US20100298322 Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use
11/25/2010US20100298319 Pyrimidine substituted purine derivatives
11/25/2010US20100298314 Novel jnk inhibitors
11/25/2010US20100298312 Substituted pyrimidinyl-amines as protein kinase inhibitors
11/25/2010US20100298310 Thiazole Derivatives as Kinase Inhibitors
11/25/2010US20100298309 Tricyclic triazolic compounds
11/25/2010US20100298302 Novel protein kinase modulators
11/25/2010US20100298295 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
11/25/2010US20100298289 Heterobicyclic compounds as histamine h4-receptor antagonists
11/25/2010US20100298285 Biclycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof
11/25/2010US20100298283 Pharmaceutical composition for enhancing immunity, and extract of poria
11/25/2010US20100298239 Peptide with multiple epitopes
11/25/2010US20100298236 Soluble gp130 muteins with improved binding activity
11/25/2010US20100298232 Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof
11/25/2010US20100298227 Treatment of autoimmune conditions with Copolymer 1 and related copolymers
11/25/2010US20100298225 Peptide gap junction modulators
11/25/2010US20100298217 Csf-1r mutants
11/25/2010US20100298216 Casein Derived Peptides And Uses Thereof in Therapy
11/25/2010US20100298214 Treatment of autoimmune disease
11/25/2010US20100297271 Compositions and methods for reducing hepatotoxicity associated with drug administration
11/25/2010US20100297250 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
11/25/2010US20100297221 pharmaceutical composition of tacrolimus
11/25/2010US20100297196 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids
11/25/2010US20100297189 Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine
11/25/2010US20100297188 Allergens and allergoids from bee venom
11/25/2010US20100297186 Multicomponent or monocomponent vaccine to be used against chagas disease, pharmaceutical compositions containing them, procedure for the obtention of immunogen of said vaccines, and nucleic acid used in said procedure
11/25/2010US20100297185 Mycobacterial mutants affecting host apoptosis
1 ... 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 ... 1172